Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation

被引:13
作者
Palmer, Amy L. [1 ]
de Jong, Annemieke [2 ]
Leestemaker, Yves [2 ,3 ]
Geurink, Paul P. [2 ,3 ]
Wijdeven, Ruud H. [2 ,3 ]
Ovaa, Huib [2 ,3 ]
Dolan, Brian P. [1 ]
机构
[1] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA
[2] Netherlands Canc Inst, Div Cell Biol 2, NL-1066 CX Amsterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Chem Immunol, NL-2333 ZC Leiden, Netherlands
基金
美国国家卫生研究院;
关键词
PEPTIDE LIGANDS; MESSENGER-RNA; PROTEASOME; PROTEIN; TRANSLATION; PRODUCTS; IMMUNOSURVEILLANCE; DEGRADATION; GENERATION; ANTIBODY;
D O I
10.4049/jimmunol.1700273
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infected or transformed cells must present peptides derived from endogenous proteins on MHC class I molecules to be recognized and targeted for elimination by Ag-specific cytotoxic T cells. In the first step of peptide generation, proteins are degraded by the proteasome. In this study, we investigated the role of the ubiquitin-specific protease 14 (Usp14), a proteasome-associated deubi-quitinase, in direct Ag presentation using a ligand-stabilized model protein expressed as a self-antigen. Chemical inhibition of Usp14 diminished direct presentation of the model antigenic peptide, and the effect was especially pronounced when presentation was restricted to the defective ribosomal product (DRiP) form of the protein. Additionally, presentation specifically from DRiP Ags was diminished by expression of a catalytically inactive form of Usp14. Usp14 inhibition did not appreciably alter protein synthesis and only partially delayed protein degradation as measured by a slight increase in the half-life of the model protein when its degradation was induced. Taken together, these data indicate that functional Usp14 enhances direct Ag presentation, preferentially of DRiP-derived peptides, suggesting that the processing of DRiPs is in some ways different from other forms of Ag.
引用
收藏
页码:928 / 936
页数:9
相关论文
共 50 条
  • [41] Quantitative measurement of the requirement of diverse protein degradation pathways in MHC class I peptide presentation
    Mamrosh, Jennifer L.
    Sherman, David J.
    Cohen, Joseph R.
    Johnston, James A.
    Joubert, Marisa K.
    Li, Jing
    Lipford, J. Russell
    Lomenick, Brett
    Moradian, Annie
    Prabhu, Siddharth
    Sweredoski, Michael J.
    Vander Lugt, Bryan
    Verma, Rati
    Deshaies, Raymond J.
    SCIENCE ADVANCES, 2023, 9 (25)
  • [42] Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination
    Wu, Weijian
    Xu, Huiying
    Liao, Chenyang
    Wang, Youqiao
    Wu, Ruirui
    Wu, Jiaxin
    Zheng, Wenlv
    Li, Yunzhi
    Jin, Chaoying
    Zhao, Yuxuan
    Quan, Junmin
    Yue, Xin
    Bu, Xianzhang
    CELLULAR ONCOLOGY, 2022, 45 (06) : 1347 - 1361
  • [43] Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I
    Simsek, Ender
    Sinnathamby, Gomathinayagam
    Block, Timothy M.
    Liu, Yuanjie
    Philip, Ramila
    Mehta, Anand S.
    Norton, Pamela A.
    VIROLOGY, 2009, 384 (01) : 12 - 15
  • [44] Polyubiquitination of lysine-48 is an essential but indirect signal for MHC class I antigen processing
    Fiebiger, Benjamin M.
    Pfister, Heike
    Behrends, Uta
    Mautner, Josef
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (03) : 716 - 727
  • [45] Vaccinia virus A35R inhibits MHC class II antigen presentation
    Rehm, Kristina E.
    Connor, Ramsey F.
    Jones, Gwendolyn J. B.
    Yimbu, Kenneth
    Roper, Rachel L.
    VIROLOGY, 2010, 397 (01) : 176 - 186
  • [46] Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action
    Lev, Avital
    Princiotta, Michael F.
    Zanker, Damian
    Takeda, Kazuyo
    Gibbs, James S.
    Kumagai, Chiharu
    Waffarn, Elizabeth
    Dolan, Brian P.
    Burgevin, Anne
    Van Endert, Peter
    Chen, Weisan
    Bennink, Jack R.
    Yewdell, Jonathan W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) : 6964 - 6969
  • [47] PROTEASOME AND CLASS-I ANTIGEN-PROCESSING AND PRESENTATION
    BELICH, MP
    TROWSDALE, J
    MOLECULAR BIOLOGY REPORTS, 1995, 21 (01) : 53 - 56
  • [48] Coupling presentation of MHC class I peptides to constitutive activation of antigen-presenting cells through the product of a single gene
    Cafri, Gal
    Amram, Eytan
    Rinott, Gal
    Koifman, Gabriela
    Fishman, Sigal
    Keisari, Yona
    Tzehoval, Esther
    Margalit, Alon
    Eisenbach, Lea
    Gross, Gideon
    INTERNATIONAL IMMUNOLOGY, 2011, 23 (07) : 453 - 461
  • [49] Epstein Barr Virus-Encoded EBNA1 Interference with MHC Class I Antigen Presentation Reveals a Close Correlation between mRNA Translation Initiation and Antigen Presentation
    Apcher, Sebastien
    Daskalogianni, Chrysoula
    Manoury, Benedicte
    Fahraeus, Robin
    PLOS PATHOGENS, 2010, 6 (10)
  • [50] Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection
    Cram, Erik D.
    Simmons, Ryan S.
    Palmer, Amy L.
    Hildebrand, William H.
    Rockey, Daniel D.
    Dolan, Brian P.
    INFECTION AND IMMUNITY, 2016, 84 (02) : 480 - 490